Iotrol, a new water-soluble non-ionic dimeric contrast medium for intrathecal use
- 1 July 1985
- journal article
- Published by Springer Nature in Neuroradiology
- Vol. 27 (4) , 337-341
- https://doi.org/10.1007/bf00339568
Abstract
The side effects associated with the use of Iotrol were determined in 100 patients and compared with metrizamide and iopamidol in two double-blind studies. The relevance of the distribution of the contrast medium in the CSF space to the occurence of headache is discussed. The low persistence of iotrol in the brain parenchyma is demonstrated on CT density profiles, compared with metrizamide and iopamidol. Iotrol seems to be the safest contrast substance for intrathecal use.Keywords
This publication has 9 references indexed in Scilit:
- Nonionic dimer: development and initial testing of an intrathecal contrast agent.Radiology, 1982
- The distribution of 125I-metrizamide and 125I-diatrizoate between blood, brain and cerebrospinal fluid in the rabbitNeuroradiology, 1980
- Iopamidol, a new non-ionic hydrosoluble contrast medium for neuroradiologyNeuroradiology, 1980
- Explanation of Metrizamide Brain PenetrationJournal of Computer Assisted Tomography, 1980
- The effect of position of patient on the passage of metrizamide (Amipaque), meglumine iocarmate (Dimer X) and ioserinate (Myelografin) into the blood after lumbar myelographyNeuroradiology, 1978
- Results of a double blind study of three contrast media and technic for lumbosacral radiculographyNeuroradiology, 1978
- Kinetics of horseradish peroxidase migration through cerebral cortexBrain Research, 1976
- Absorption of Metrizamide from Cerebrospinal Fluid to Blood: Pharmacokinetics in HumansJournal of Pharmaceutical Sciences, 1975
- Clinical and experimental studies on headache after myelographyNeuroradiology, 1975